A detailed history of Quantitative Investment Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantitative Investment Management, LLC holds 5,212 shares of REGN stock, worth $3.97 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
5,212
Previous 4,552 14.5%
Holding current value
$3.97 Million
Previous $4.78 Million 14.53%
% of portfolio
0.54%
Previous 0.52%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1024.09 - $1201.76 $675,899 - $793,161
660 Added 14.5%
5,212 $5.48 Million
Q2 2024

Aug 14, 2024

SELL
$883.2 - $1071.19 $2.73 Million - $3.31 Million
-3,091 Reduced 40.44%
4,552 $4.78 Million
Q1 2024

May 15, 2024

SELL
$902.69 - $993.35 $15.8 Million - $17.4 Million
-17,552 Reduced 69.66%
7,643 $7.36 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $17.1 Million - $19.5 Million
22,087 Added 710.65%
25,195 $22.1 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $2.15 Million - $2.62 Million
3,108 New
3,108 $2.56 Million
Q1 2023

May 15, 2023

BUY
$680.49 - $826.97 $9.91 Million - $12 Million
14,556 New
14,556 $12 Million
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $13 Million - $17.5 Million
-23,747 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$595.12 - $698.43 $9.84 Million - $11.6 Million
16,540 Added 229.5%
23,747 $16.6 Million
Q4 2021

Feb 14, 2022

SELL
$543.48 - $670.97 $4.34 Million - $5.35 Million
-7,980 Reduced 52.54%
7,207 $4.55 Million
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $6.41 Million - $7.61 Million
11,175 Added 278.54%
15,187 $9.19 Million
Q2 2021

Aug 16, 2021

BUY
$472.8 - $558.54 $1.9 Million - $2.24 Million
4,012 New
4,012 $2.24 Million
Q1 2020

May 15, 2020

SELL
$336.18 - $494.43 $5.91 Million - $8.69 Million
-17,572 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $4.82 Million - $6.62 Million
17,572 New
17,572 $6.6 Million
Q2 2019

Aug 14, 2019

SELL
$299.6 - $414.82 $149,800 - $207,410
-500 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$372.08 - $439.57 $818,576 - $967,054
-2,200 Reduced 81.48%
500 $205,000
Q4 2018

Feb 12, 2019

BUY
$335.82 - $403.04 $67,164 - $80,608
200 Added 8.0%
2,700 $1.01 Million
Q3 2018

Nov 14, 2018

BUY
$351.14 - $408.51 $877,850 - $1.02 Million
2,500 New
2,500 $1.01 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.